Lactobacillus plantarum Bianquejun 18, Lactobacillus plantarum preparation and application thereof

By developing acid, bile salt and drug resistance, Bian Quejun, plantarum 18, the side effects and insufficient resistance of existing hypoglycemic drugs were solved, and the α-glucosidase and α-amylase were achieved. Inhibition, significantly improves blood sugar control in diabetic mice, and is suitable for the production of a variety of foods and health products.

CN115838661BActive Publication Date: 2024-11-12HEBEI YUZHILIN PHARMA +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211292095.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-20
Publication Date
2024-11-12
Estimated Expiration
2042-10-20

AI Technical Summary

Technical Problem

Existing anti-glycemic drugs will have serious side effects during use, and Lactobacillus plantarum is easily inhibited by gastric juice and bile salts after entering the human body, and is insufficiently resistant to other drugs, making it difficult to effectively reduce blood sugar and adapt to the gastrointestinal environment. .

Method used

Developed a plant-based Lactobacillus Bian Quejun 18. This strain has inhibitory effects on α-glucosidase and α-amylase, is acid-resistant, bile salt-resistant and drug-resistant, and can colonize in the intestines, suitable for preparation Foods, medicines and health care products that lower blood sugar.

Benefits of technology

Lactobacillus plantarum Bian Quejun 18 significantly improved the sugar tolerance of type 2 diabetic mice, delayed the fasting and postprandial blood sugar rise of hyperglycemia, and had excellent antioxidant properties and antibacterial ability. It is suitable for the production of yogurt and antioxidant products. , ensuring its auxiliary effect of lowering blood sugar.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115838661B_ABST
    Figure CN115838661B_ABST
Patent Text Reader

Abstract

The present invention relates to the field of microbial technology, and proposes a plant lactobacillus and its application in hypoglycemic treatment, including a plant lactobacillus (lactobacillus plantarum) Bian Que Jun 18, wherein the plant lactobacillus Bian Que Jun 18 is deposited in the General Microbiological Center of the China Microbiological Culture Collection Administration Committee, and the deposit number is CGMCC No. 25712. Through the above technical scheme, a plant lactobacillus Bian Que Jun 18 having both auxiliary hypoglycemic effect and adaptability to the gastrointestinal environment and having acid resistance, bile salt resistance and drug resistance is provided.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of microorganisms, and in particular to a plant lactobacillus Bianquejun 18 and an application thereof in reducing blood sugar. Background Art

[0002] As one of the main killers of health at present, diabetes has received great attention. As a metabolic disease with multiple causes, it causes hyperglycemia in the body due to disorders in sugar, fat and protein metabolism caused by insufficient insulin secretion or defects in the body. There are type I and type II diabetes. Type I diabetes relies on exogenous insulin supplementation to maintain life due to lack of insulin secretion. Type II diabetes patients account for the highest proportion, mainly due to insulin resistance or insufficient insulin secretion, and patients suffer from high blood sugar all year round. There are currently five main types of oral hypoglycemic drugs, including α-glucosidase inhibitors, sulfonylureas, meglitinides, biguanides and thiazolidinones, but the use of these drugs can cause serious side effects.

[0003] Studies have shown that probiotics are active microecological preparations that promote the health of a class of hosts, and their good functional characteristics and health-promoting effects have been widely accepted and recognized. Plant lactobacillus is the main probiotic species, and some studies have also confirmed that it has a certain degree of hypoglycemic effect (such as CN111733111B). But plant lactobacillus can be inhibited by gastric juice and bile salts after entering the human body, so the acid and bile salt resistance of bacterial strain is very important, and similarly, along with the universal use of antibiotics, bacterial strain is also very important for the resistance of other drugs. Therefore, it is a problem to be solved urgently for those skilled in the art to develop a functional strain that has both auxiliary hypoglycemic effect and can adapt to the gastrointestinal environment and has acid resistance, bile salt resistance, and drug resistance. Summary of the invention

[0004] The purpose of the present invention is to provide a plant lactobacillus Bianquejun 18 which has an auxiliary hypoglycemic effect, can adapt to the gastrointestinal environment, and is acid-resistant, bile-resistant, and drug-resistant.

[0005] In order to achieve the above-mentioned object of the invention, the technical solution of the present invention is as follows:

[0006] A lactobacillus plantarum (lactobacillus plantarum) Bian Que Jun 18, which was deposited in the General Microbiology Center of China National Committee for the Preservation of Microorganisms (address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing) on ​​September 15, 2022, with a preservation number of CGMCC No. 25712.

[0007] As a further technical solution, the obtaining of the plant lactobacillus Bianquejun 18 comprises the following steps:

[0008] S1. After the Shijiazhuang pickle solid is crushed, it is extracted with 0.85% sterile physiological saline to obtain an extract;

[0009] S2, add the extract to the physiological saline and mix well, then dilute it tenfold, take 10 -4 , 10-5, 10 -6 The samples of three dilutions were evenly spread on solid MRS medium containing 0.5% CaCO3 and cultured at 37°C for 36-48h;

[0010] S3. After culturing for 36-48 hours, select colonies with obvious transparent circles, purify them, and store them on a slant in a refrigerator at 4°C to obtain Lactobacillus plantarum Bianquejun 18.

[0011] As a further technical solution, the plant lactobacillus preparation includes the plant lactobacillus Bian Que Jun 18 described in claim 1.

[0012] As a further technical solution, the Lactobacillus plantarum preparation is in solid or liquid state.

[0013] As a further technical solution, the plant lactobacillus preparation includes one or more of live bacteria of plant lactobacillus Bianquejun 18, inactivated bacteria of plant lactobacillus Bianquejun 18, and metabolites of plant lactobacillus Bianquejun 18.

[0014] As a further technical solution, the Lactobacillus plantarum preparation is used in preparing yogurt.

[0015] As a further technical solution, the Lactobacillus plantarum preparation is used in the preparation of a product for lowering blood sugar in the body.

[0016] As a further technical solution, the Lactobacillus plantarum preparation is used in the preparation of a product for improving the body's glucose tolerance.

[0017] As a further technical solution, the plant lactobacillus preparation is used in the preparation of a product for reducing the content of glycosylated hemoglobin in the body.

[0018] As a further technical solution, the product includes food, medicine or health care product.

[0019] The working principle and beneficial effects of the present invention are:

[0020] 1. In the present invention, plant lactobacillus Bian Que Jun 18 has a good inhibitory effect on both α-glucosidase and α-amylase, especially has an outstanding inhibitory effect on α-amylase. At the same time, it has acid resistance, bile salt resistance, and drug resistance. In addition, it also has excellent intestinal colonization ability and can adapt to the human gastrointestinal environment, so that its blood sugar lowering effect is affected by the external environment as much as possible, ensuring its auxiliary blood sugar lowering effect. In addition, it has been confirmed by in vitro experiments that plant lactobacillus Bian Que Jun 18 has a significant improvement effect on the glucose tolerance of type 2 diabetic mice, and can significantly delay the increase of fasting blood sugar and postprandial blood sugar in hyperglycemic mice, and improve the glucose tolerance of hyperglycemic mice. Therefore, plant lactobacillus Bian Que Jun 18 is suitable for preparing foods, medicines and health products that assist in lowering blood sugar.

[0021] 2. The plant lactobacillus Bianquejun 18 of the present invention has a fast acid production rate during the fermentation process of yogurt, which reduces the production cost. L. plantarum Bianquejun 18 shows excellent performance in coagulation time, fermented milk acidity, acid production rate during fermentation, water retention rate, viable bacteria count, acidity change during storage, viable bacteria count change during storage, and syneresis shrinkage rate change during storage, and is suitable for use in the preparation of yogurt.

[0022] 3. The plant lactobacillus Bianquejun 18 of the present invention has a high scavenging rate for hydroxyl radicals, superoxide anion radicals and DPPH radicals, has good antioxidant properties, and can be used to prepare antioxidant products.

[0023] 4. The plant lactobacillus Bianquejun 18 of the present invention contains rich antibacterial substances and has good antibacterial ability, and can be used to prepare antibacterial products. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] The present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments.

[0025] Figure 1 The colony morphology of the seven strains screened is shown in Figure 2.

[0026] Figure 2 The Gram-stained bacterial morphology of Bianquejun 18 and SCSBC9;

[0027] Figure 3 This is a comparison chart of AUC of each group of mice after the hyperglycemia model was successfully established;

[0028] Figure 4 This is a comparison of the AUC of each group of mice after one week of oral administration;

[0029] Figure 5 This is a comparison chart of AUC of each group of mice at the end of the experiment;

[0030] Figure 6Schematic diagram of pH changes during fermentation of fermented milk;

[0031] Figure 7 This is a schematic diagram of the acidity changes during the fermentation of fermented milk;

[0032] Figure 8 This is a schematic diagram of the change in the number of live bacteria during the fermentation process of fermented milk;

[0033] Fig. 9 This is a schematic diagram of the acidity changes during the storage period of fermented milk;

[0034] Fig.10 This is a schematic diagram of the change in the number of live bacteria during the storage period of fermented milk;

[0035] Fig.11 This is a schematic diagram of the changes in the syneresis shrinkage rate of fermented milk during the storage period. DETAILED DESCRIPTION

[0036] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0037] Example 1. Screening and identification of Lactobacillus plantarum Bianquejun 18

[0038] 1.1 In this embodiment, the raw materials and instruments used in the experiment are as follows:

[0039] 1.1.1 Experimental samples

[0040]

[0041] It should be noted that those skilled in the art know that all solid samples contain fermentation liquid. In addition, Sample No. 2 and Sample No. 3 come from different farmers' naturally fermented kimchi, but Sample No. 2 carries less kimchi fermentation liquid when sampling, while Sample No. 3 carries less solid kimchi when sampling.

[0042] 1.1.2 Culture medium

[0043] MRS medium: glucose 20 g, peptone 10 g, beef extract 10 g, yeast extract powder 5 g, anhydrous sodium acetate 5 g, dipotassium hydrogen phosphate 2 g, triammonium citrate 2 g, manganese sulfate 0.25 g, magnesium sulfate 0.58 g, Tween-80 1 mL, pH 6.2-6.4, autoclave at 121 °C for 15 min.

[0044] MRS solid culture medium: Add 1.5% agar to MRS liquid culture medium and sterilize by high pressure at 115℃ for 15 minutes.

[0045] CaCO3-MRS solid medium: MRS liquid medium supplemented with 1.5% CaCO3 and 1.5% agar.

[0046] Nutrient broth medium (NB): 3 g beef extract, 10 g peptone, 5 g sodium chloride, pH 7.2-7.4, autoclave at 121°C for 20 min.

[0047] 1.1.3 Indicator bacteria

[0048] Staphylococcus aureus ATCC 25923. Escherichia coli ATCC 44752.

[0049] 1.1.4 Experimental reagents

[0050]

[0051]

[0052] 1.1.5 Experimental equipment

[0053]

[0054] 1.2 Screening of strains

[0055] 1.2.1 Sample processing

[0056] Solid samples of Anhui pickles, Sichuan pickles, Shijiazhuang pickles, Sichuan water cabbage, Meizhou pickles, and Yunnan fermented loquat were crushed and extracted with sterile saline (0.85% by mass). The sample extracts were pipetted into test tubes and stored in a 4°C refrigerator for later use.

[0057] The Sichuan pickle fermentation liquid was directly pipetted into a test tube and stored in a 4°C refrigerator for later use.

[0058] 1.2.2 Screening of strains

[0059] Use a pipette to aseptically pipette 0.5 mL of the solid sample extract and Sichuan pickle fermentation liquid. Suspend the samples in test tubes containing 4.5 mL of sterile saline (0.85% by mass) and mix them evenly on a vortex oscillator. After mixing evenly, perform ten-fold gradient dilutions in sequence. Take 10 mL of each sample into each test tube. -4 , 10 -5 , 10 -6The samples of three dilutions were evenly spread on solid MRS medium containing 0.5% CaCO3, and then placed at 37°C for 36-48h. The colonies with obvious transparent circles were observed and selected, numbered, and streaked on MRS plates for multiple times. Purification was performed until the colony morphology was uniform, and a single colony was selected to be cultured on MRS solid medium for 24h, stored on a slant, and the characteristics of the colony were recorded. The colony was then placed in a 4°C refrigerator for standby use, and 7 strains were obtained, which were numbered AHPC4, SCPC6, SCPCFJY, Bian Que Jun 18, SCSBC9, MZPC2, and YNPP5.

[0060] 1.2.3 Preparation of bacterial suspension and fermentation broth

[0061] Pick the screening strains preserved on the slant, add them to a 250mL Erlenmeyer flask containing 50mL MRS, and culture them at 37℃ for 24h to obtain the first-generation bacterial suspension. Take the first-generation bacterial suspension and inoculate it into a 250mL Erlenmeyer flask containing 50mL MRS at a 1% inoculation amount. Culture them at 37℃ for 12h to obtain the second-generation bacterial suspension. Centrifuge the continuously activated second-generation bacterial suspension at 4000rpm and 4℃ for 10min to separate the supernatant. Pass the supernatant separated by centrifugation through a 0.22μm microporous filter membrane as the fermentation supernatant of the strain; take the centrifuged precipitated bacteria, wash them 2-3 times with 0.85% saline, and resuspend them to adjust the bacterial suspension to 1×10 9 CFU / mL (OD value = 1.0) to obtain bacterial suspension. The 7 strains screened were all treated as above to obtain corresponding bacterial suspension.

[0062] 1.3 Identification of strains

[0063] 1.3.1 Morphological observation of strains

[0064] The selected strains preserved on the slant in step 1.2.2 were selected and inoculated into MRS liquid medium. They were cultured at 37°C for 2 generations. After continuous activation, they were streaked on a solid CaCO3-MRS plate with an inoculation loop. After 48 hours of culture at 37°C, the characteristics of the colonies were observed. The 7 strains obtained by screening were all treated as above. The results are as follows: Figure 1 As shown. Figure 1 It can be seen that the colony morphology of the seven strains is similar, with a colony diameter between 0.2-2.0 mm, a colony color of milky white, a round convex shape, neat edges, translucent, and a moist and smooth surface. Among them, 6 strains are rod-shaped and 1 strain is spherical, which is strain SCSBC9 ( Figure 1 ).

[0065] The isolated strains were subjected to Gram staining and microscopic examination: fix the slide on the clean bench, pick an appropriate amount of single colonies, evenly spread them on the slide, heat with an alcohol lamp flame, and fix the bacteria. Use crystal violet for initial staining for 1 minute, rinse with distilled water, and use absorbent paper to absorb excess water. Use iodine-potassium iodide solution for mordant dyeing for 1 minute, use absorbent paper to absorb excess water, decolorize with 95% ethanol for 30 seconds, rinse with distilled water, and use absorbent paper to absorb excess water. Finally, use safranin to re-stain for 30 seconds, rinse with distilled water, and use absorbent paper to absorb excess water. Finally, observe under a microscope. Blue-purple is Gram-positive bacteria, and red is Gram-negative bacteria. The screened Bian Quejun 18 and SCSBC9 strains were subjected to the above treatments, and the results are as follows Figure 2 shown. Figure 2 The microscopic morphological characteristics of the bacteria Bianquejun 18 and SCSBC9 are shown. The Gram staining results of both strains showed purple. Both strains are Gram-positive bacteria and do not form spores.

[0066] Description: Submitted in the application text Figure 1-2 The actual experimental results are not very clear, so additional supporting documents are submitted. Supporting documents 1-2 are Figure 1-2 Original image (color image).

[0067] The next step is to conduct the H2O2 enzyme test. Take a glass slide, use a pipette (1-10μL) to transfer a few drops of 3% (v / v) H2O2, evenly distribute it on the surface of the glass slide, pick a single colony of the strain, fully dissolve it in H2O2, and check whether bubbles are generated within 30s. Repeat the test three times for each experimental strain. The 7 strains screened were all treated as above, and the results are shown in Table 1. According to Table 1, all 7 strains were negative for H2O2 enzyme.

[0068] Table 1 Morphological and physicochemical characteristics of strains

[0069]

[0070] 1.3.2 Molecular biological identification of strains

[0071] The strain was activated on MRS solid medium for three generations until a single colony was obvious. The activated strain was sent to Shanghai Shenggong Biological Co., Ltd. for 16S rDNA sequence determination of the strain, and the 16S rDNA sequence was submitted to the NCBI database. The gene sequence was compared using BLAST to analyze the homology of the strain. The 7 strains screened were all treated as above, and the results are shown in Table 2. According to Table 2, Bian Quejun 18, SCPCFJY, MZPC2, SCPC6, AHPC4 and YNPP5 belong to plant lactobacillus; among them, Bian Quejun 18, SCPC6 and AHPC4 have 100% homology with the 16S rDNA sequence of plant lactobacillus, and SCSBC9 belongs to Pentosaceae. Table 3 shows the analysis and naming of the strain identification results.

[0072] Table 2 NCBI database comparison results

[0073]

[0074]

[0075] Table 3 Analysis and naming of strain identification results

[0076]

[0077] Based on the above results, it can be seen that the screened lactic acid bacteria Bianquejun 18 is determined to be Lactobacillus plantarum.

[0078] Example 2: Confirmation of hypoglycemic ability of Lactobacillus plantarum Bianquejun 18

[0079] 2.1 Inhibition rate of α-amylase

[0080] Prepare a mixed solution according to Table 4, and finally add distilled water to dilute to 5mL, use a pipette to take 200μL of strain fermentation liquid or bacterial suspension, add 100μL of α-amylase (0.05mg / mL), mix the two and keep warm at 37℃ for 10min, then add 625μL of starch (0.1%) solution, react at 37℃ for 15min, add 300μL of 1.0mol / L HCl to terminate the reaction, add 200μL of iodine solution (0.01mol / L) for color development, finally add distilled water to make the volume 5mL, and measure the absorbance A at a wavelength of 660nm. The 7 strains screened and the corresponding bacterial suspension (prepared in Example 1) were all treated as above. The calculation formula is as follows:

[0081]

[0082] In the formula: A1—negative blank OD 660 Value; A2—negative control OD 660 Value; A3—sample blank OD660 Value; A4—sample control OD 660 value.

[0083] Table 4 Experiment on the inhibition rate of α-amylase by Lactobacillus plantarum Bianquejun 18

[0084]

[0085]

[0086] The results of the inhibition of α-amylase by the 7 strains and their corresponding bacterial suspensions are shown in Table 5. Table 5 shows that the fermentation supernatants of the 7 strains have a high inhibition rate on α-amylase, and the best inhibitory effect is the strain Bian Que Jun 18, with an inhibition rate of 47.33%, which is much better than the existing technology, and is of great significance for the application of Bian Que Jun 18 in assisting blood sugar reduction; while the 7 bacterial suspensions have no obvious inhibitory effect on α-amylase, all within 5%.

[0087] Table 5 Inhibitory effect of Lactobacillus plantarum Bianquejun 18 on α-amylase

[0088]

[0089] 2.2 Inhibition rate of α-glucosidase

[0090] Accurately pipette 100 μL of sample solution (strain fermentation supernatant or bacterial suspension), add 100 μL of α-glucosidase (1U / mL), incubate at 37°C for 10 min, then add 500 μL of PNPG (1mmol / L), then culture at 37°C for 20 min, finally add 1 mL of Na2CO3 (0.2 mol / L) to terminate the reaction, and measure the absorbance at a wavelength of 405 nm. The 7 strains screened and the corresponding bacterial suspension (prepared in Example 1) were all treated as above. The calculation formula is as follows:

[0091]

[0092] Where: A—OD of solution containing α-glucosidase but without sample 405 B—OD value of solution without α-glucosidase and sample to be tested 405 Value; C—OD value of α-glucosidase solution and sample to be tested 405 D—OD value of the solution without α-glucosidase but containing the sample to be tested 405 value.

[0093] Table 6 Inhibitory effect of Lactobacillus plantarum Bianquejun 18 on α-glucosidase

[0094]

[0095] The inhibitory effects of the seven strains and their corresponding bacterial suspensions on α-glucosidase are shown in Table 6. According to Table 6, the seven lactic acid bacteria and their fermentation supernatants all have a certain inhibitory effect on α-glucosidase. Among them, in the fermentation supernatant, Bianquejun 18 and SCPCFJY have the highest inhibition rate on α-glucosidase; in the bacteria, SCPCFJY has the highest inhibition rate on α-glucosidase.

[0096] Based on the above results, it can be seen that Lactobacillus plantarum Bianquejun 18 has a good inhibitory effect on both α-glucosidase and α-amylase, indicating that Lactobacillus plantarum Bianquejun 18 has an excellent auxiliary blood sugar-lowering effect.

[0097] Example 3: Hypoglycemic effect of Lactobacillus plantarum Bianquejun 18 on diabetic mice

[0098] It should be noted that K m Mice were purchased from the Animal Research Center of Hebei Medical University.

[0099] 3.1 Preparation of live bacteria preparation and metabolites of Lactobacillus plantarum Bianquejun 18

[0100] L. plantarum Bianquejun 18 was activated in liquid MRS medium and cultured at 37°C for 24 hours. After two generations of continuous activation, L. plantarum Bianquejun 18 in the logarithmic growth phase was inoculated into MRS medium at a 1% inoculum amount at 36°C and pH 7. The glucose in the MRS medium was replaced with an equal amount of maltose and cultured at a constant temperature. Samples were taken every 2 hours to measure the OD value of the bacterial solution. 600 value.

[0101] The two bacterial cells were collected separately, and the bacterial cells were resuspended with 12% skim milk as a protective agent, and vacuum freeze-dried to prepare solid powder live bacterial preparations. The fermentation supernatants of the two bacterial cells were collected separately, and vacuum freeze-dried for 36 hours to prepare solid samples of fermentation metabolites, namely, fermentation supernatant freeze-dried agents.

[0102] 3.2 In vivo experiments in mice

[0103] 3.2.1 Experimental mouse grouping and establishment of diabetes model

[0104] The experimental mice were grouped and fed according to Table 7, with no less than 10 mice in each group. In the first week, only the basic feed was fed. At the beginning of the second week, intraperitoneal injection was performed according to Table 7. From the beginning of the second week, the blood glucose of the mice was measured (using the method of cutting the tail to draw blood, using a blood glucose meter and blood glucose test strips for measurement), once a week.

[0105] Table 7 Grouping and feeding of experimental mice

[0106]

[0107] One week after STZ was intraperitoneally injected into mice (i.e., at the beginning of the third week since the start of feeding), the fasting blood glucose and postprandial blood glucose of mice were measured. The mice were fasted but not watered for 12 hours, and the fasting blood glucose was measured; the mice were fed, and the postprandial blood glucose was measured 2 hours later. The results are shown in Tables 8 and 9.

[0108] Table 8 Fasting blood glucose of mice in each group after successful modeling

[0109]

[0110] Table 9 Postprandial blood glucose of mice in each group after successful modeling

[0111]

[0112] According to Tables 8 and 9, except for the control group in group N, the fasting blood glucose values ​​of the other groups were higher than the normal value of 7.0mmol / L, and the blood glucose 2h after meal was higher than 11.0mmol / L. According to the fasting blood glucose and postprandial blood glucose values ​​of mice (fasting blood glucose>7.0mmol / L, blood glucose 2h after meal>11.0mmol / L), it can be judged that the type 2 diabetes mouse model was successfully established.

[0113] The mental state of mice in each group: The mice in the normal group and group N showed normal activity and were full of energy; the body shape of the mice was observed, and the hair was sufficient and intact, white and smooth, and the shape was normal. The diet and drinking water of the mice were normal, and the feces were black. The mice in the high blood sugar group showed abnormal performance, mental depression, thin body, yellow hair that was easy to fall off, and the amount of drinking water and urination increased significantly, and the feces were gray.

[0114] 3.2.2 Blood glucose status of type Ⅱ diabetic mouse model after drug treatment

[0115] Very important indicators for the medical diagnosis of type 2 diabetes are the body's fasting blood sugar and postprandial blood sugar. Through adaptive feeding, random grouping, constructing hyperglycemic mice, and measuring the fasting and postprandial blood sugar of mice. After measuring the postprandial blood sugar of mice in step 3.2.1, the mice will be gavaged according to Table 7. Before gavage, the live bacteria preparation of Bian Que Jun 18 needs to be processed. The processing method is: dilute the live bacteria preparation prepared in 3.1 above with physiological saline (0.85%), and adjust the number of live bacteria to 1×10 9 CFU / mL and 1×10 8 CFU / mL, and mice were gavaged after 30 minutes of constant temperature water bath at 37°C. One week after gavage (i.e., at the beginning of the 4th week since the start of feeding), the fasting blood glucose and postprandial blood glucose of mice were measured, and the results are shown in Tables 10 and 11.

[0116] Table 10 Changes of fasting blood glucose in mice

[0117]

[0118] Table 11 Changes of blood glucose after meal in mice

[0119]

[0120] As shown in Tables 10 and 11, from the beginning of modeling to the third week, except for the N group, the fasting blood glucose levels of the other groups increased significantly. Subsequently, the fasting blood glucose level of the P group began to decrease. After continuous drug administration, the fasting blood glucose level of the treatment group began to slowly approach that of the normal group. Starting from the fifth week, the blood glucose growth rate of the M group was much greater than that of the other groups, and the fasting blood glucose of the other treatment groups was significantly lower than that of the M group. Although Bian Que Jun 18 (1), Bian Que Jun 18 (2) and Bian Que Jun 18 (3) could not achieve the effect of the P group. However, compared with the M group, both the fasting blood glucose of hyperglycemic mice and the postprandial blood glucose of hyperglycemic mice were improved to a certain extent under the action of Bian Que Jun 18. This proves that Lactobacillus plantarum Bian Que Jun 18 can be used in foods, medicines and health products that assist in lowering blood sugar.

[0121] 3.2.3 Oral glucose tolerance test in mice

[0122] Glucose tolerance is an important reference for the clinical diagnosis of diabetes, and the oral glucose tolerance test is used as a criterion. After the model was successfully established, each group of mice was tested for changes in blood sugar through an oral glucose experiment. The detection direction of oral glucose tolerance of mice is as follows: after measuring fasting blood sugar, each group of mice was gavaged with glucose solution (2g / Kg), and the blood sugar content of mice was measured at 15, 30, 60, 90 and 120 minutes. The test was carried out after the model was successfully established (i.e., at the beginning of the third week from the start of feeding), one week after gavage (i.e., at the beginning of the fourth week from the start of feeding), and at the end of the experiment (i.e., the 11th week from the start of feeding). The results are shown in Tables 12 and Figure 3 .

[0123] Table 12 Changes in glucose tolerance of mice in each group after the hyperglycemia model was successfully established

[0124]

[0125]

[0126] After the model was successfully established and before drug administration, the blood glucose changes of mice in each group were tested by oral glucose administration. The results are shown in Tables 12 and Figure 3 According to Table 12 and Figure 3It can be seen that within 15 minutes of oral administration, the blood sugar levels of mice in each group rose rapidly, and the blood sugar rate of mice in the hyperglycemia group was higher than that of mice in the normal group; after 15 minutes, the blood sugar level of mice in the normal group began to decline, and returned to normal levels after 2 hours; while the blood sugar level of mice in the hyperglycemia group declined slowly after 15 minutes, and still maintained high blood sugar levels after 2 hours, and the glucose tolerance ability was significantly reduced.

[0127] Table 13 Changes in glucose tolerance of mice in each group after oral administration for one week (mmol / L)

[0128]

[0129] One week after intragastric administration, the glucose tolerance results of mice in each group are shown in Table 13 and Figure 4 According to Table 13 and Figure 4 It can be seen that the blood sugar changes in the P group were roughly consistent with the trend of changes a week ago. Within 15 minutes of intragastric administration, the blood sugar of the mice in the hyperglycemia group continued to increase, and there was still a short-term increase after 30 minutes. The blood sugar recovery of the mice in the hyperglycemia group showed a significant downward trend after intragastric administration one week compared with a week ago, and the AUC value of the mice in the intragastric administration group was significantly different from that of the M group. This shows that Bian Que Jun 18 can improve the glucose tolerance of hyperglycemic mice.

[0130] Table 14 Changes in glucose tolerance of mice in each group at the end of the experiment (mmol / L)

[0131]

[0132] At the end of the experiment, the results of glucose tolerance in each group are shown in Table 14 and Figure 5 From Table 14 and Figure 5 It can be seen that the blood sugar value of group N has not changed from before, and the glucose tolerance remains stable and can be restored to normal levels. The blood sugar value and tolerance of the treatment group P are close to those of group N, indicating that the treatment effect is significant. The AUC values ​​of the other experimental groups are significantly different from those of group M, and the rate and amplitude of blood sugar increase are also significantly lower than those of group M, and the rate of decrease is more obvious than that of group M. This shows that Lactobacillus plantarum Bian Que Jun 18 has a significant improvement effect on the glucose tolerance of type 2 diabetic mice. This proves that Lactobacillus plantarum Bian Que Jun 18 can be used to prepare a composition that improves the body's glucose tolerance.

[0133] 3.2.4 Mouse glycosylated hemoglobin detection

[0134] Glycosylated hemoglobin (HbA1c) can be used as an indicator to evaluate blood sugar control in patients with diabetes. The content of glycosylated hemoglobin in plasma can be used as an indicator of blood sugar control. Glycosylated hemoglobin less than 8.3mmol / L indicates ideal blood sugar control. The specific operation steps are as follows: After the experiment, weigh the organs of the mice, calculate the organ ratio and glycosylated hemoglobin content. Glycosylated hemoglobin uses an ELISA kit, refer to the instructions, and the results are shown in Table 15.

[0135] As shown in Table 15, there was no significant difference in organ ratio coefficients among the mice in each group, indicating that feeding lactic acid bacteria and fermentation liquid had no effect on the organs of mice. Compared with the N group, the glycosylated hemoglobin content of the P group was less than 8.3mmol / L, and the difference was not significant, indicating that the glycosylated hemoglobin of the hyperglycemic mice was significantly improved after a period of treatment. Compared with the N group, the glycosylated hemoglobin content of the hyperglycemic mice was higher, all higher than 8.3mmol / L, indicating that the hyperglycemic mice had persistent hyperglycemia. Compared with the M group, the glycosylated hemoglobin of the Bian Que Jun 18 (1), Bian Que Jun 18 (2) and Bian Que Jun 18 (3) experimental groups decreased. This indicates that feeding Lactobacillus plantarum Bian Que Jun 18 can improve the content of glycosylated hemoglobin. This proves that Lactobacillus plantarum Bian Que Jun 18 can be used to prepare products that reduce the content of glycosylated hemoglobin in the body.

[0136] Table 15 Effects of plant lactobacillus Bianquejun 18 on organ coefficients and blood sugar indexes of mice in each group

[0137]

[0138] Note: Letters indicate significance, the same letters indicate no significant difference, different letters indicate significant difference, and the significance level is P<0.05.

[0139] Example 4: Confirmation of drug resistance of Lactobacillus plantarum Bianquejun 18

[0140] In the present embodiment, amikacin, kanamycin, gentamicin, streptomycin, norfloxacin, ofloxacin, levofloxacin, ciprofloxacin, vancomycin, erythromycin, tetracycline, ceftriaxone, cefotaxime, penicillin G, nitrofurantoin, chloramphenicol, and clindamycin were all purchased from Tiantan Biological Products Co., Ltd. and were all analytically pure.

[0141] 4.1 Strain activation

[0142] 100 μL of the fermentation broth of the strain in Example 1 was taken and inoculated into MRS liquid medium, cultured at 37° C. for 24 h, subcultured twice to the logarithmic phase, and then used. The fermentation broths of the above 7 strains were all subjected to the above treatment.

[0143] 4.2 Drug sensitivity testing

[0144] The antibiotic sensitivity of the 7 strains was tested by the drug sensitivity paper diffusion method. According to the latest version of the manual of the Clinical and Laboratory Standards Institute (CLSI), the drug resistance activity of the 7 strains was tested. The test results are shown in Table 16.

[0145] Table 16 Drug resistance results of strains

[0146]

[0147] Note: “R” stands for drug resistance; “I” stands for between drug resistance and sensitivity; “S” stands for sensitivity.

[0148] The drug resistance of the strain is an important criterion for evaluating the safety of the strain. It can be seen from Table 16 that the drug resistance of Lactobacillus plantarum Bian Que Jun 18 is the best. It is only resistant to oxazolidinone antibiotics and is sensitive to other types. It has high safety and can ensure that Lactobacillus plantarum Bian Que Jun 18 will hardly be affected by other drugs after taking it, further ensuring the auxiliary blood sugar lowering function of Lactobacillus plantarum Bian Que Jun 18, improving the auxiliary blood sugar lowering effect, and further facilitating the application of Lactobacillus plantarum Bian Que Jun 18 in the preparation of auxiliary blood sugar lowering foods, medicines and other fields.

[0149] Example 5: Confirmation of the acid resistance, bile resistance and NaCl resistance of Lactobacillus plantarum Bianquejun 18

[0150] 5.1 Acid resistance

[0151] Pepsin was dissolved in 0.5% sodium chloride solution, and the pH was adjusted to 2.0, 3.0 and 4.0, with a final concentration of 0.3%. After fully dissolved, it was sterilized by filtration with a 0.22μm microporous membrane (the whole process was sterile). The second-generation strain was inoculated into simulated artificial gastric fluid, and cultured at a constant temperature of 37°C. Samples were taken at 0h, 2h, and 4h, and the number of viable bacteria was determined by the plate dilution method, and the survival rate was calculated.

[0152] The 7 strains obtained in Example 1 were all subjected to the above treatment. The calculation formula for the survival rate is as follows:

[0153]

[0154] Where: N is the number of viable lactic acid bacteria before treatment (CFU / mL); Na is the number of viable lactic acid bacteria after treatment (CFU / mL).

[0155] The survival rate results of the 7 strains are shown in Table 17. According to Table 17, after the in vitro acid resistance experiment, the strains showed different acid resistance. In the environment of pH 4.0, the survival rates of the 7 strains were all above 90%; but under low acid conditions, the tolerance differences of the strains were more obvious. After incubation for 2 hours under pH 2.0 conditions, the survival rate of Bian Que Jun 18 was significantly higher than that of other strains, specifically 72.95±1.65. After incubation for 4 hours under pH 2.0 conditions, the survival rate of Bian Que Jun 18 was still significantly higher than that of other strains, specifically 50.71±1.32. Secondly, SCSBC9 also showed better acid resistance. This proves that after taking Lactobacillus plantarum Bian Que Jun 18, it can maintain a high survival rate in the gastric fluid environment, further ensuring the auxiliary hypoglycemic function of Lactobacillus plantarum Bian Que Jun 18, improving the auxiliary hypoglycemic effect, and further facilitating the application of Lactobacillus plantarum Bian Que Jun 18 in the preparation of auxiliary hypoglycemic foods, medicines and other fields.

[0156] Table 17 Acid resistance test results

[0157]

[0158] 5.2 Bile salt tolerance

[0159] The 7 strains obtained in Example 1 were subjected to bile salt resistance experiments. The specific experimental steps are as follows: accurately weigh 0.68g of potassium dihydrogen phosphate, dissolve it with 50mL of water, adjust the pH to 6.8, dissolve pig bile salt with 50mL of water and mix it with potassium dihydrogen phosphate solution to make the final concentrations of 0.1%, 0.2%, and 0.3%. Take the second-generation lactic acid bacteria and add them to the prepared simulated intestinal fluid, culture them at a constant temperature of 37°C, take samples at 0h, 2h, and 4h, determine the number of viable bacteria by plate dilution method, and calculate the survival rate. The calculation formula of the survival rate is the same as the acid resistance formula, which will not be repeated here.

[0160] Table 18 Bile salt tolerance test results

[0161]

[0162] The survival results of the 7 strains are shown in Table 18. According to Table 18, after incubation for 2 hours at a bile salt concentration of 0.3%, the survival rates of the 7 strains were all above 60%, and the bile salt tolerance was good. After incubation for 4 hours at a bile salt concentration of 0.3%, the survival rates of the 7 strains were all above 50%, and the bile salt tolerance was still very good. This proves that after taking Lactobacillus plantarum Bian Que Jun 18, it can maintain a high survival rate in the intestinal fluid environment, further ensuring the auxiliary blood sugar lowering function of Lactobacillus plantarum Bian Que Jun 18, improving the auxiliary blood sugar lowering effect, and further facilitating the application of Lactobacillus plantarum Bian Que Jun 18 in the preparation of auxiliary blood sugar lowering foods, medicines and other fields.

[0163] 5.3 NaCl tolerance

[0164] NaCl was added to the MRS liquid culture medium according to different ratios, with NaCl concentrations of 0%, 2%, 4%, 6%, 7%, 8%, and 9% respectively. After high temperature and high pressure sterilization, the strains in the logarithmic growth phase were inoculated with 1% inoculum in the MRS culture medium, cultured at 37°C for 18h, and the OD value of the bacterial suspension was measured at a wavelength of 600nm. The 7 strains obtained in Example 1 were all treated as above.

[0165] Table 19 NaCl resistance test results

[0166]

[0167] The results of NaCl resistance test of the seven strains are shown in Table 19. According to Table 19, when NaCl exceeds 4%, the bacterial volume of the other strains drops sharply, while when the NaCl concentration is 9%, Bianquejun 18 can still grow 60%, showing excellent NaCl tolerance.

[0168] In summary, Lactobacillus plantarum Bian Que Jun 18 has excellent acid resistance, alkali resistance and NaCl tolerance, which can ensure that Lactobacillus plantarum Bian Que Jun 18 is not disturbed by these factors in the gastrointestinal environment, further ensure the auxiliary blood sugar lowering function of Lactobacillus plantarum Bian Que Jun 18 and improve the auxiliary blood sugar lowering effect.

[0169] Example 6: Confirmation of the hydrophobicity of Lactobacillus plantarum Bianquejun 18

[0170] PBS solution (0.01 mol / L, pH 7.4) was used to adjust the OD of each strain. 600 4 mL of A0 was mixed with 400 μL of xylene, vortexed for 3 min, and then allowed to stand for 30 min. After separation, the aqueous phase was collected and the OD was measured. 600 Absorbance value (A1).

[0171] The 7 strains obtained in Example 1 were all treated as above. 600 The absorbance value (A1) is calculated as follows:

[0172]

[0173] Where: A0—initial bacterial solution OD 600 Value; A1—OD of aqueous phase after separation 600 value.

[0174] Table 20 Hydrophobicity measurement results

[0175]

[0176] The results of the hydrophobicity determination of the 7 strains are shown in Table 20. According to Table 20, SCPCFJY has the best hydrophobicity, which is 65.80, followed by Bian Que Jun 18 and AHPC4, and the hydrophobicity is also higher than 50%. The hydrophobicity of these three strains is significantly higher than that of other strains. Those skilled in the art know that hydrophobicity is the main factor affecting the adhesion of strains. Studies have shown that strains with high hydrophobicity on the bacterial surface have higher adhesion; the hydrophobicity of the strain cell membrane is positively correlated with the adhesion ability, which can be used as an indicator to examine the adhesion ability of the strain; strains with strong adhesion are more likely to colonize in the human intestine. According to the measurement results, the strong hydrophobicity of Bian Que Jun 18 can ensure that Bian Que Jun 18 colonizes in the human intestine, further promotes the hypoglycemic effect, and improves the effect of auxiliary hypoglycemic effect.

[0177] Example 7: Confirmation of the fermentation performance of Lactobacillus plantarum Bianquejun 18

[0178] The strains in this example are the 7 strains obtained in Example 1. The skim milk powder in this example was purchased from Shanghai Bright Dairy. The rotary viscometer NDJ-5S in this example was purchased from Shanghai Lunjie Electromechanical Instrument Co., Ltd.

[0179] 7.1 Determination of coagulation time of fermented milk

[0180] The strain was activated to the logarithmic phase, inoculated with 2% inoculum in 10% (w / v) sterilized skim milk, and kept at a constant temperature of 37°C. The coagulation status was observed every 2 hours and the coagulation time was recorded. Three parallels were performed in each group. The coagulation time and the termination time of fermentation after single-bacteria fermentation were determined in skim milk (containing 1% glucose). The 7 strains obtained in Example 1 were all treated as above, and the results are shown in Table 21. As can be seen from Table 21, the coagulation time of each strain is very different, among which L. plantarum MZPC2 still did not form coagulation after 48 hours; while the coagulation time of L. plantarum Bian Que Jun 18, L. plantarum SCPCFJY and P. pentosaceus SCSBC9 was shorter, and their coagulation times were 14 hours, 14 hours and 12 hours respectively.

[0181] Table 21 Coagulation time of fermented milk

[0182]

[0183] It should be noted that since the coagulation time of L. plantarum MZPC2 and L. plantarum AHPC4 was too long to be used in yogurt preparation, no subsequent determination was performed.

[0184] 7.2 Determination of fermented milk acidity and pH during fermentation

[0185] The acid production ability of lactic acid bacteria affects the overall quality of fermented milk. A fast acid production rate will affect the protein cross-linking of the fermented milk, resulting in the loss of flavor substances and a decline in taste; a slow acid production rate will cause losses in the development and market promotion of fermented milk, waste energy and time, and increase production costs.

[0186] After the fermentation of the five strains began, the pH value of the fermented milk was measured with a pH meter every 4 hours until the fermentation was terminated. Figure 6 As shown. Figure 6 It can be seen that the acid production capacity of each strain is different. The titrated acidity during the fermentation process continues to increase. As the fermentation time increases, the acid production rate of lactic acid bacteria reaches a certain value and gradually stabilizes. The time when the pH of each fermented milk reaches below 4.6 is significantly different. The acid production rate of L. plantarum SCPCFJY is slower, taking about 40 hours; the acid production rate of L. plantarum Bian Que Jun 18 is the fastest, taking about 24 hours.

[0187] After the strain is activated, it is inoculated into 10% (w / v) sterilized skim milk at a 2% inoculum, cultured at a constant temperature of 37°C, and immediately refrigerated at 4°C for 24 hours after curdling, and then the acidity of the fermented milk is measured. The acidity is measured according to the method of GB / T 5009.239-2016 "Determination of Acidity of Foods", expressed in degrees Girner (°T). The test was repeated 3 times and the average value was taken. The 5 strains obtained in Example 1 were all treated as above. The results are as follows Figure 7 As shown. Those skilled in the art know that the acid production capacity of lactic acid bacteria is best between 70 and 110°T. Figure 7 It can be seen that at the end of curdling, the acidity of L. plantarum Bianquejun 18 was better, between 100 and 110°T.

[0188] 7.3 Determination of water retention rate of fermented milk

[0189] One of the important quality indicators of coagulated yogurt is water holding capacity. Five strains activated to the logarithmic phase were inoculated at 2% in 10% (w / v) sterilized skim milk, cultured at a constant temperature of 37°C, and refrigerated at 4°C for 24 hours after coagulation. Take 10 mL of fermented milk respectively, put it into a centrifuge tube and centrifuge (13200r / min, 4°C) for 20 minutes, pour off the supernatant, measure the water retention rate and titrated acidity of the fermented milk, and conduct sensory evaluation. Each group was repeated 3 times in parallel, and the results are recorded in Table 22. The water retention rate is calculated as follows:

[0190]

[0191] Where: M—centrifuge tube mass (g); M a—mass of sample and centrifuge tube (g); M b —Mass of sample and centrifuge tube after centrifugation (g).

[0192] The specific sensory evaluation process of fermented milk is as follows: the skimmed fermented milk after curdling is refrigerated for 24 hours, and the fermented milk is evaluated based on its color, taste, smell, and texture. The sensory evaluation members consist of 7 people who have received professional sensory training. The sensory scoring standards are shown in Table 22. After the sensory evaluation is completed, the results are recorded in Table 23.

[0193] Table 22 Fermented milk sensory evaluation table

[0194]

[0195]

[0196] According to the data in Table 23, the water retention rate of L. plantarum Bianquejun 18 is 66.42% ± 0.28%, the acidity is 76.42 ± 0.28°T, and the sensory evaluation is 51.32 ± 2.33, and its performance in these three aspects is relatively good.

[0197] Table 23 Fermented dairy products experimental results

[0198]

[0199] 7.4 Determination of viable bacterial count in fermented milk

[0200] 0.5 mL of fermented milk was accurately measured and diluted with saline (0.85%) and the number of viable bacteria in the fermented milk was calculated by MRS medium plate coating method. The results are shown in Figure 8 .Depend on Figure 8 It can be seen that L. plantarum Bianquejun 18 has entered the logarithmic growth phase after 6 hours of fermentation, and is basically in the stable phase for 24 hours. The number of viable bacteria after reaching the stable phase is about 9.25 logarithmic values.

[0201] 7.5 Changes in acidity during storage of fermented milk

[0202] The flavor, quality, and shelf life of yogurt are related to the change in acidity during storage. The method for determining the acidity of fermented milk during storage is consistent with that in Example 7.2. The results are as follows: Fig. 9 As shown. Fig. 9 It can be seen that the acidity of all strains tended to increase gradually during the cold storage period. Among them, L. plantarum Bianquejun 18 and L. plantarum SB5 had the smallest increase in titrated acidity, increasing by 13.51°T and 12.77°T respectively, and their post-acidification ability was the weakest.

[0203] 7.6 Changes in viable bacterial count during storage of fermented milk

[0204] Qualified fermented milk products must maintain stable physical and chemical properties during the shelf life, and the number of viable bacteria must be within a reasonable range to achieve the beneficial effects of fermented milk. The method for determining the number of viable bacteria during the storage period of fermented milk is consistent with that in Example 7.2. The results are as follows: Fig.10 As shown. Fig.10 It can be seen that although L. plantarum Bianquejun 18 also showed a downward trend after one week, its decline rate was the slowest and its live bacteria count was the highest, indicating that its physical and chemical properties were the most stable during the storage period.

[0205] 7.7 Changes in syneresis shrinkage during storage of fermented milk

[0206] The dehydration shrinkage capacity and viscosity of fermented milk are mainly related to the structure of fermented milk. The looser the structure of fermented milk during storage, the easier it is for water molecules to precipitate, and the quality and flavor will decline; the tighter the structure of fermented milk, the less water molecules will precipitate, so the dehydration shrinkage capacity is an important indicator for evaluating the quality and stability of fermented milk. The method for measuring the dehydration shrinkage rate is as follows: accurately weigh 5.0g of fermented milk, place it in a funnel at a constant temperature (20℃, 90min), collect the filtrate and weigh it, repeat 3 times and take the average value, the results are shown in the table. Fig.11 The calculation formula of syneresis is as follows:

[0207]

[0208] Where, M is the sample mass (g); M1 is the filtrate mass (g).

[0209] The results of STS changes of the five fermented milks during storage are shown in Fig.11 .Depend on Fig.11 It can be seen that the syneresis ability of L. plantarum Bianquejun 18 is still relatively good.

[0210] It can be seen from Example 7 that L. plantarum Bian Que Jun 18 shows excellent performance in coagulation time, fermented milk acidity and acid production rate during fermentation, water retention rate, viable bacteria count, acidity change during storage, viable bacteria count change during storage and dehydration shrinkage rate change during storage, and is suitable for use in the preparation of yogurt.

[0211] Example 8 Confirmation of the antioxidant capacity of Lactobacillus plantarum Bianquejun 18

[0212] The antibacterial abilities of the seven strains screened in Example 1 were determined.

[0213] 8.1 Hydroxyl free radical scavenging ability

[0214] Take a 10mL centrifuge tube, add 0.5mL of salicylic acid-ethanol solution (5mmol / L), 0.5mL of ferrous sulfate (5mmol / L), 0.5mL of H2O2 (3mmol / L) and 1mL of strain fermentation supernatant or bacterial suspension in sequence, mix well, and dilute to 5mL with double distilled water. Incubate at 37°C for 15min, centrifuge at 4°C and 4000rpm for 15min, aspirate the supernatant, and measure the absorbance at 510nm. Add 1mL of 1mmol / L ascorbic acid as a positive control. The 7 strains and their bacterial suspensions obtained in Example 1 were all treated as above, and the results are recorded in Table 24. The hydroxyl radical scavenging ability is calculated as follows:

[0215]

[0216] Where: Ao—OD without sample 510 Value; As—OD of sample 510 value;

[0217] 8.2 Superoxide Anion Scavenging Capacity

[0218] Take 0.1mL of the fermentation supernatant or bacterial suspension sample, add 4.5mL of Tris-HCl (pH8.2, 150mmol / L), water bath at 25℃ for 20min, add 0.4mL, 1.2mmol / L of pyrogallol, water bath at 25℃ for 5min, immediately add 2 drops of 8mol / L HCl to terminate the reaction, take the supernatant and measure the absorbance at 325nm (with double distilled water as reference). The 7 strains and their bacterial suspensions obtained in Example 1 were all treated as above, and the results are recorded in Table 24. The superoxide anion scavenging ability calculation formula is as follows:

[0219]

[0220] Where: Ao—OD without sample 325 Value; As—OD of sample 325 value.

[0221] 8.3DPPH scavenging ability

[0222] Take 1mL of the fermentation supernatant or bacterial suspension and 1mL of DPPH anhydrous ethanol solution (0.2mmol / L) and shake and mix, react at room temperature in the dark for 30min, and centrifuge at 6000rpm for 10min. Take the centrifugal supernatant and measure the absorbance at 517nm. An equal volume of anhydrous ethanol replaces the DPPH solution as the blank group, and an equal volume of distilled water replaces the sample solution as the control group. The 7 strains and their bacterial suspensions obtained in Example 1 were all treated as above, and the results are recorded in Table 24. The DPPH scavenging ability calculation formula is as follows:

[0223]

[0224] Where: A1—OD without sample 517 Value; A2—contains the OD of the sample 517 Value; A3—OD of blank group 517 value.

[0225] It can be seen from Table 24 that the fermentation supernatant of Lactobacillus plantarum Bianquejun 18 has good antioxidant properties in terms of the scavenging rate of hydroxyl radicals. The fermentation supernatant and the bacterial cells of Lactobacillus plantarum Bianquejun 18 have good antioxidant properties in terms of the scavenging rate of superoxide anion radicals and DPPH radicals. This proves that Lactobacillus plantarum Bianquejun 18 can be used in the preparation of antioxidant products.

[0226] Table 24 Determination results of antioxidant capacity

[0227]

[0228] Example 9: Confirmation of the antibacterial ability of Lactobacillus plantarum Bianquejun 18

[0229] The antibacterial abilities of the seven strains screened in Example 1 were determined.

[0230] 9.1 Acid removal

[0231] The strains were cultured in MRS medium for 24 h, and the fermentation supernatant was obtained by centrifugation, and the pH value was measured. The pH value was then adjusted to 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, and 7.0. The seven strains obtained in Example 1 were all treated as described above. The antibacterial activity of the fermentation supernatants of the seven strains was measured by the Oxford cup agar diffusion method.

[0232] 9.2 Temperature Sensitivity

[0233] The fermentation supernatants of the seven strains were heat treated at 80℃ and 121℃ for 15 min, respectively. The antibacterial activity of the fermentation supernatants was determined by the Oxford cup agar diffusion method, and the temperature sensitivity of the fermentation supernatants was analyzed by the size of the inhibition zone.

[0234] 9.3 Enzyme sensitivity

[0235] The sensitivity of the fermentation supernatants of 7 strains to trypsin, proteinase K, proteinase E, pepsin and catalase was studied. Pepsin was dissolved in 50mmol / L, pH 2.0 Na2HPO4-citric acid buffer, and other enzymes were dissolved in 50mmol / L, pH 7.5 Tris-HCl buffer. A certain amount of enzyme solution was mixed evenly with the sterile supernatant of the strain, the final concentration of the enzyme solution was 10mg / mL, 37℃ constant temperature water was used for 2h, and the reaction was completed. The 100℃ boiling water bath was used for 5min to completely inactivate the enzyme. The solution after enzyme inactivation was adjusted to the initial pH value of the fermentation supernatant with 0.1mol / L HCl or NaOH, centrifuged at 6000r / min for 10min, and the supernatant was collected. The fermentation supernatants of the 7 strains obtained in Example 1 were all treated as above. After the supernatant was collected, the antibacterial activity of the fermentation supernatant was determined by the Oxford cup agar diffusion method. Among them, the control group was the fermentation supernatant that was not treated with enzymes.

[0236] Table 25 Antibacterial effect

[0237]

[0238] It can be seen from Table 25 that the antibacterial performance of Bianquejun 18 against Escherichia coli and Staphylococcus aureus is higher than that of the other six strains, and has better antibacterial ability. This proves that Lactobacillus plantarum Bianquejun 18 can be used in food, medicine and health products to improve antibacterial properties.

[0239] Example 10 Determination of organic acid content of Lactobacillus plantarum Bianquejun 18

[0240] The organic acids of the seven strains screened in Example 1 were measured.

[0241] The seven strains were cultured in MRS medium for 24 hours, and the fermentation supernatants were obtained by centrifugation. After being filtered through a 0.22 μm membrane, high performance liquid chromatography was performed. Organic acid standards (oxalic acid, citric acid, formic acid, propionic acid, pyroglutamic acid, malic acid, hydroxyphenyllactic acid, lactic acid, acetic acid, butyric acid and phenyllactic acid) of different concentrations of 1-500 μg / mL were prepared respectively, and their peak areas were detected by HPLC. The horizontal axis was the organic acid content, and the vertical axis was the peak area. The standard curve of organic acids was drawn, and the content of organic acids in the fermentation broth was calculated according to the organic acid standard curve. Chromatographic conditions: Waters e2695 high performance liquid chromatograph and Aminex HPX-87H column (300mm×7.8mm) were used, the mobile phase was 5mmol / L dilute sulfuric acid solution, isocratic elution, flow rate 0.5mL / min, detection wavelength 210nm, column temperature 50℃, injection volume 20μL. The results of the organic acid content of the seven strains are shown in Table 26.

[0242] Table 26 Organic acid content determination results

[0243]

[0244]

[0245] According to the results in Table 26, the organic acids in the fermentation supernatants of the seven strains are mainly lactic acid and acetic acid. In addition, a third-generation new antibacterial substance, phenyllactic acid, was also detected. The lactic acid content in the fermentation supernatant of the Bian Que Jun 18 strain fermentation broth was the highest, at 9.97 mg / mL, followed by acetic acid 2.40 mg / mL, and the content of phenyllactic acid was 0.046 mg / mL. This proves that the organic acid antibacterial substance content produced by the fermentation supernatant of the Bian Que Jun 18 strain is the highest and the antibacterial ability is the best, which is further conducive to the application of plant lactobacillus Bian Que Jun 18 in the preparation of antibacterial products.

[0246] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A Lactobacillus plantarum ( lactobacillus plantarum ) Bian Que Jun 18, characterized by, The plant lactobacillus Bianquejun 18 is deposited in the General Microbiology Center of China Microorganism Culture Collection Administration, with the deposit number of CGMCC No.25712.

2. A plant lactobacillus preparation, characterized in that The plant lactobacillus preparation comprises the plant lactobacillus Bianquejun 18 described in claim 1.

3. The plant lactobacillus preparation according to claim 2, characterized in that The plant lactobacillus preparation is in solid or liquid state.

4. The plant lactobacillus preparation according to claim 2, characterized in that The plant lactobacillus preparation comprises one or both of plant lactobacillus Bianquejun 18 live bacteria and fermentation supernatant of plant lactobacillus Bianquejun 18 live bacteria.

5. Application of the plant lactobacillus Bianquejun 18 according to claim 1 or the plant lactobacillus preparation according to claim 2 in preparing yogurt.

6. Use of the plant lactobacillus Bianquejun 18 according to claim 1 or the plant lactobacillus preparation according to claim 2 in the preparation of a medicament for treating type II diabetes.

7. Use of the plant lactobacillus Bianquejun 18 according to claim 1 or the plant lactobacillus preparation according to claim 2 in the preparation of a health product for reducing blood sugar.